Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Tuesday Talk: Zig-Zag-ing Away
Article By:
TalkMarkets DailyTalk
Tuesday, April 19, 2022 6:41 AM EDT
The market returned from the Good Friday long weekend by starting up then turning down then turning up, turning down, up again and down again, before closing out the day nearly unchanged.
S 3 DRIP Stocks With Rising Dividends
Article By:
SureDividend
Tuesday, April 19, 2022 6:04 AM EDT
Dividend Reinvestment Plan (DRIP) stocks allow you to automatically reinvest incoming dividend payments. We discuss the prospects of three high-quality, no-fee DRIP stocks - XOM, ABBV and AFL.
2 Great Dividend Stocks To Buy Now To Help Tackle Inflation
Article By:
Benjamin Rains
Friday, April 8, 2022 4:33 AM EDT
Wall Street turned its focus back to the possibility of higher interest rates as the Fed is indicating a more hawkish turn to help combat 40-year high inflation.
5 Leading Healthcare Stocks Surging On Pent-up Demand
Just a hunch. The healthcare industry is highly regulated and Dems generally favor more regulation, making it more difficult for drugmakers to secure the necessary regulatory approvals to market new products. Regulatory changes could drastically alter a healthcare stock’s growth prospects, for instance. But I reckon I'll not sell $ABBV after holding during all the long downward spiral.
5 Leading Healthcare Stocks Surging On Pent-up Demand
Seems health stocks should do well but a #Biden presidency will not favor this sector. $ABBV $PFE
Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.
AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
How much debt does $ABBV have?
AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
$ABBV certainly sounds like a great buy.
AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).